These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11555755)

  • 21. Human herpesvirus-8 infection of umbilical cord-blood-derived CD34+ stem cells enhances the immunostimulatory function of their dendritic cell progeny.
    Larcher C; Nguyen VA; Fürhapter C; Ebner S; Sölder E; Stössel H; Romani N; Sepp N
    Exp Dermatol; 2005 Jan; 14(1):41-9. PubMed ID: 15660918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional alteration of myeloid dendritic cells through head and neck cancer.
    Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
    Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment.
    Paczesny S; Li YP; Li N; Latger-Cannard V; Marchal L; Ou-Yang JP; Bordigoni P; Stoltz JF; Eljaafari A
    J Leukoc Biol; 2007 Apr; 81(4):957-67. PubMed ID: 17229904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
    Zhou CJ; Ma W; Zhou JD; Zhao YX; Xie HQ
    Ai Zheng; 2006 Feb; 25(2):143-7. PubMed ID: 16480575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
    Di Nicola M; Carlo-Stella C; Mortarini R; Baldassari P; Guidetti A; Gallino GF; Del Vecchio M; Ravagnani F; Magni M; Chaplin P; Cascinelli N; Parmiani G; Gianni AM; Anichini A
    Clin Cancer Res; 2004 Aug; 10(16):5381-90. PubMed ID: 15328176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
    Nitsch SM; Pries R; Wollenberg B
    In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.
    Young MR; Lathers DM
    Int J Immunopharmacol; 1999 Apr; 21(4):241-52. PubMed ID: 10408632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship among lymphatic metastasis, pericancerous lymphocytic reaction and dendritic cell infiltration in laryngeal carcinoma cells].
    Feng Y; Zhang B; Tan H; Su H; He W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):264-6. PubMed ID: 12761992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells.
    Young MR; Wright MA; Lozano Y; Prechel MM; Benefield J; Leonetti JP; Collins SL; Petruzzelli GJ
    Int J Cancer; 1997 Feb; 74(1):69-74. PubMed ID: 9036872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ex vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells.
    Kobari L; Giarratana MC; Gluckman JC; Douay L; Rosenzwajg M
    Stem Cells; 2006 Sep; 24(9):2150-7. PubMed ID: 16946001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells.
    Karcher J; Dyckhoff G; Beckhove P; Reisser C; Brysch M; Ziouta Y; Helmke BH; Weidauer H; Schirrmacher V; Herold-Mende C
    Cancer Res; 2004 Nov; 64(21):8057-61. PubMed ID: 15520216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein.
    Frenzel H; Pries R; Brocks CP; Jabs WJ; Wittkopf N; Wollenberg B
    Anticancer Res; 2007; 27(6B):4111-5. PubMed ID: 18225580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
    Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
    Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood transfusions and phenotypic immune profile in head and neck cancer patients undergoing surgical resection.
    MacRae JD; Lampe H; Banerjee D
    J Otolaryngol; 1991 Oct; 20(5):310-4. PubMed ID: 1960784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of poor CD3 response in head and neck cancer.
    Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
    Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.